Sodium-glucose Co-transporter 2 Inhibitors in Acute Heart Failure: A Review of the Available Evidence and Practical Guidance on Clinical Use

Sodium-glucose Co-transporter 2 Inhibitors in Acute Heart Failure: A Review of the Available Evidence and Practical Guidance on Clinical Use

Sodium-glucose co-transporter 2 (SGLT2) inhibitors were initially conceived as glucose-lowering agents. However, striking renal and cardiovascular benefits were observed in type 2 diabetes trials. This led to evaluate it in dedicated studies in chronic heart failure (HF) and chronic kidney disease,...

Full description

Bibliographic Details
Main Authors: Herminio Morillas, Emilio Galcerá, Edgardo Alania, Julia Seller, Ainhoa Larumbe, Julio Núñez, Alfonso Valle
Format: Article
Language:English
Published: IMR Press 2022-04-01
Series:Reviews in Cardiovascular Medicine
Subjects:
sglt2 inhibitors
heart failure
acute
admission
congestion
safety
Online Access:https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304139

Internet

https://www.imrpress.com/journal/RCM/23/4/10.31083/j.rcm2304139

Similar Items